Covid19 Clinical Trial - Study of seroPREvalence Vis-à-vis SARS-CoV2 &

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05047601` - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection	Phase 3
Recruiting	`NCT04481633` - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection	N/A
Recruiting	`NCT05323760` - Functional Capacity in Patients Post Mild COVID-19	N/A
Active, not recruiting	`NCT04612972` - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru	Phase 3
Completed	`NCT04537949` - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults	Phase 1/Phase 2
Recruiting	`NCT05191394` - IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON ACQUIRED VACCINAL ANTI-SARS-CoV-2 ANTIBODIES.	N/A
Active, not recruiting	`NCT05158816` - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting	`NCT04341506` - Non-contact ECG Sensor System for COVID19
Recruiting	`NCT04512079` - FREEDOM COVID-19 Anticoagulation Strategy	Phase 4
Active, not recruiting	`NCT04384445` - Zofin (Organicell Flow) for Patients With COVID-19	Phase 1/Phase 2
Terminated	`NCT04498273` - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80	Phase 3
Enrolling by invitation	`NCT05089305` - Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection	Phase 2
Recruiting	`NCT04357990` - Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19	N/A
Active, not recruiting	`NCT04527471` - Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19	Phase 2
Recruiting	`NCT05041907` - Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)	Phase 2
Active, not recruiting	`NCT05022329` - COVID-19 Vaccine Boosters in Patients With CKD	Phase 2/Phase 3
Not yet recruiting	`NCT04990466` - Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.	Phase 2/Phase 3
Recruiting	`NCT04661462` - Health After Covid-19 in Tyrol
Recruiting	`NCT05323799` - The Optimising Isolation, Quarantine and Distancing Study for COVID-19 (Optimise)
Not yet recruiting	`NCT04446065` - Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers	Phase 2/Phase 3

NCT number	NCT04528901
Study type	Observational
Source	University Hospital, Strasbourg, France
Contact	Céline MASCAUX
Phone	+ 3 33 69 55 06 44
Email	[email protected]
Status	Recruiting
Phase
Start date	September 4, 2020
Completion date	December 2022

Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital) — PRESAGE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms